Jon Stonehouse

(Mr. Jon Stonehouse)

Currently holds positions in Bellicum Pharmaceuticals Inc and BioCryst Pharmaceuticals Inc

Positions
Position Company Period
Independent Director Bellicum Pharmaceuticals Inc Dec. 5, 2014 -
President, Chief Executive Officer, Director BioCryst Pharmaceuticals Inc July 13, 2007 -
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Total value Details
2024-05-15 2024-05-13
B Purchase
30,000 +2.7%
5.55
166,500 USD 		30,000 +2.7% 5.55 166,500 USD
2023-02-02 2023-02-01
PS Planned sale
100,000 -9.0%
10.38
1,038,000 USD 		100,000 -9.0% 10.38 1,038,000 USD
2022-12-19 2022-12-15
PS Planned sale
14,100 -1.6%
10.90
153,690 USD 		14,100 -1.6% 10.90 153,690 USD
2022-12-02 2022-12-02
PS Planned sale
82,656 -8.4%
12.80
1,057,997 USD 		82,656 -8.4% 12.80 1,057,997 USD
2022-12-02 2022-12-01
PS Planned sale
214,917 -19.2%
13.00
2,793,921 USD 		214,917 -19.2% 13.00 2,793,921 USD
2022-01-13 2022-01-11
PS Planned sale
184,000 -16.9%
15.04
2,767,360 USD 		184,000 -16.9% 15.04 2,767,360 USD
2020-12-17 2020-12-15
PS Planned sale
134,278 -14.6%
8.32
1,117,193 USD 		134,278 -14.6% 8.32 1,117,193 USD